1. Proceedings of the 10th National Conference on Anticoagulant Therapy

   • David A. Garcia

   EditorialNotes 17 November 2009 Pages: 147 - 147

2. Development of national performance measures on the prevention and treatment of venous thromboembolism

   • Dale W. Bratzler

   OriginalPaper 15 November 2009 Pages: 148 - 154

   

3. How to meet national quality initiatives: best practices

   • Katherine Phillips Cabral

   OriginalPaper 12 November 2009 Pages: 155 - 158

4. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts

   • Greg Maynard
   • Jason Stein

   OriginalPaper Open access 10 November 2009 Pages: 159 - 166

   

5. Impact on patient care: patient case through the continuum of care

   • Scott Kaatz

   OriginalPaper 10 November 2009 Pages: 167 - 170

6. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient

   • Michael Makris
   • Joost J. van Veen
   • Rhona Maclean

   OriginalPaper 01 November 2009 Pages: 171 - 181

7. New oral anticoagulants: a practical guide for clinicians

   • Ann K. Wittkowsky

   OriginalPaper 04 November 2009 Pages: 182 - 191

8. To bridge or not to bridge: that is the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures

   • Alex C. Spyropoulos

   OriginalPaper 02 November 2009 Pages: 192 - 198

9. Update on heparin: what do we need to know?

   • Daniel S. Weitz
   • Jeffrey I. Weitz

   OriginalPaper 02 November 2009 Pages: 199 - 207

   

10. Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

    • Marco P. Donadini
    • James D. Douketis

    OriginalPaper 15 November 2009 Pages: 208 - 213

11. Is patient self-testing a good thing?

    • Lynn B. Oertel
    • Edward N. Libby

    OriginalPaper 10 November 2009 Pages: 214 - 218

12. What you should know about the 2008 American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th) on Antithrombotic and Thrombolytic Therapy

    • Scott Kaatz

    OriginalPaper 17 November 2009 Pages: 219 - 226

13. The financial viability of an anticoagulation clinic: a discussion from the anticoagulation forum meeting, May, 2009

    • Henry I. Bussey

    OriginalPaper 14 November 2009 Pages: 227 - 232

14. Using low molecular weight heparin in special patient populations

    • Wendy Lim

    OriginalPaper 10 November 2009 Pages: 233 - 240

15. Proceedings of the 10th National Conference on Anticoagulant Therapy

    Events 10 November 2009 Pages: 241 - 264